AFG
JAZZ icon

Atomi Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Atomi Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Buy
2,110
+269
+15% +$47K 0.01% 807
2025
Q4 		$313K Buy
+1,841
New +$282K 0.01% 909

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Atomi Financial Group's JAZZ Position: Q1 2026 in Review

Atomi Financial Group increased its Jazz Pharmaceuticals (JAZZ) stake by 15% in Q1 2026, buying an estimated $47K and bringing the position to 2,110 shares worth $399K. The position accounts for 0.01% of the portfolio, ranked #807.

Atomi Financial Group first reported a position in JAZZ in Q4 2025 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Atomi Financial Group held 2,110 shares of Jazz Pharmaceuticals worth $399K as of Q1 2026.
  • Atomi Financial Group bought 269 Jazz Pharmaceuticals shares in Q1 2026, an estimated $47K.
  • Jazz Pharmaceuticals made up 0.01% of Atomi Financial Group's portfolio in Q1 2026, its #807 holding.
  • Atomi Financial Group first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.